Excerpted from daily Google News Alerts. Stories are
in date order with most recent stories at the top.
Motley
Fool – USA
The company was trying to get Satraplatin approved to treat
hormone-refractory prostate cancer in patients
whose prior chemotherapy has failed. …
Pressure
for Provenge Approval
BusinessWeek
- USA
A prostate cancer patient group files suit,
demanding an FDA green light of Dendreon’s vaccine. Investors are on
board, too by Catherine Arnst A group …
Good
news for prostate
cancer patients
TopCancerNews.com
- Dallas,TX,USA
There’s good news for prostate cancer patients
who’ve had the disease spread to other parts of the body — a new
treatments, currently being tried out on …
Clarient
and Health Discovery Corporation Initiate Alliance with …
CNNMoney.com
- USA
Under the terms of the agreement, Clarient obtained an exclusive
license to HDC’s prostate cancer marker and plans
to immediately initiate the …
OncoGenex
and Isis Report Encouraging Interim Phase II Data in …
CNNMoney.com
- USA
“Docetaxel is the only agent to have demonstrated a survival benefit in
patients with hormone refractory prostate cancer,”
said Cindy Jacobs, MD, …
